5/7
11:28 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
5/7
11:28 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
5/7
08:02 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
5/7
08:01 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
5/7
05:32 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
5/7
05:32 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
4/10
08:05 am
bcrx
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Low
Report
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/10
07:08 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX
4/10
07:08 am
bcrx
Rating for BCRX
Low
Report
Rating for BCRX